Ana Stancic serves as Executive at Omrix Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Ana Stancic has executed 7 insider transactions totaling $20.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 26, 2014 involved purchasing 8,000 shares valued at $20.0K.
Ana Stancic currently holds 8,000 shares of Omrix Biopharmaceuticals, Inc. (OMRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ana Stancic has been a net buyer of OMRI stock. They have purchased $20.0K and sold $0 worth of shares.
Ana Stancic's most recent insider trade was on Nov 26, 2014, when they purchased 8,000 shares at $2.50 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 17, 2012 | ENZN | $0 | Disposition | 45,000 | $N/A | Discretionary |
| Nov 17, 2011 | ENZN | $0 | Award | 45,000 | $N/A | Discretionary |
| Jun 8, 2011 | ENZN | $0 | Award | 25,000 | $N/A | Discretionary |
| Jun 24, 2010 | KVA/KVB | $0 | Award | 7,500 | $N/A | Discretionary |
| Oct 1, 2007 | OMRI | $0 | Award | 8,000 | $N/A | Discretionary |